Pharma 2020 : The vision - which path will you take?
If you want to understand why the pharmaceutical industry is currently undergoing a transition, I am recommending you to read this interesting report from PricewaterhouseCoopers.
PWC clearly “indicates that the current pharmaceutical industry business model is both economically unsustainable and operationally incapable of acting quickly enough to produce the types of innovative treatments demanded by global markets. In order to make the most of these future growth opportunities, the industry must fundamentally change the way it operates.”
As I mentioned earlier, it is clear that the Pharma. must quickly find the way to improve its R&D productivity. For us, it is only by measuring the performance that the companies are able to set goals and drive for improvement. This has been demonstrated in others business as finance, and ultimately will prove itself in Drug or Medical Device Development.
Do not hesitate to share your impression with us!
Pharma 2020 : The vision - which path will you take?
A report from PricewaterhouseCoopers
Clinical Trial Performance - why should we assess it?
Have you ever been asked to “reduce the costs to develop new pharmaceutical products and / or to reduce time to market”? Yes? Then you will be interested in sharing your experience and ideas on this matter!
No comments
